Contact Dermatitis Clinical Trial
Official title:
Clinical Evaluation of Hydroxyisohexyl 3-cyclohexene Carboxaldehyde (Lyral®) Dose Response Study
The purpose of this study is to determine optimal allergen dose as the lowest concentration eliciting positive reactions in 70-90% of subjects. Frequency of positive, negative, doubtful and irritant reactions, and concordance with a corresponding reference allergens will be captured.
This is a single-center, randomized study to compare the diagnostic performance and safety of ascending doses (0.10 mg/cm², 0.20 mg/cm² and 0.40 mg/cm²) of hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral®) in 20 adult subjects with a past positive patch test to Lyral® or Fragrance Mix 2. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00371163 -
Molecular and Cellular Characterization of Spongiotic Dermatitis
|
N/A | |
Completed |
NCT02028208 -
Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study
|
Phase 2 | |
Not yet recruiting |
NCT04853823 -
A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB
|
Phase 1 | |
Recruiting |
NCT06387472 -
DermAI to Evaluate Human Factor of Testing
|
N/A | |
Completed |
NCT02700373 -
A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03089775 -
Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis
|
Phase 1 | |
Completed |
NCT04438135 -
Children With Aluminium Contact Allergy: Cutaneous Exposure Study
|
N/A | |
Recruiting |
NCT06189144 -
Testing an Intervention in Irritative Contact Dermatitis
|
N/A | |
Completed |
NCT04921163 -
Children With Aluminium Contact Allergy: Oral Exposure Study
|
N/A | |
Not yet recruiting |
NCT02026700 -
Bariederm Cream in Chronic Contact Dermatitis
|
N/A | |
Completed |
NCT00824889 -
Exploratory Study of Natural Killer Cells in Human Skin
|
N/A | |
Completed |
NCT00646867 -
Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis
|
N/A | |
Withdrawn |
NCT01518348 -
Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
|
Phase 3 | |
Recruiting |
NCT03705182 -
Prevention of Dermatitis in Epoxy Exposed Workers
|
N/A | |
Terminated |
NCT03198390 -
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
|
||
Completed |
NCT00614289 -
Novel Topical Treatment of Hand Dermatitis (Eczema)
|
Phase 1 | |
Recruiting |
NCT06331390 -
Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis
|
N/A | |
Completed |
NCT00640614 -
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
|
Phase 3 | |
Completed |
NCT00640250 -
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response
|
Phase 2 | |
Recruiting |
NCT06177314 -
Molecular Diagnosis of Allergic Contact Dermatitis
|